Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
15.23
-0.66 (-4.15%)
Aug 14, 2025, 11:39 AM - Market open
Immunovant Market Cap
Immunovant has a market cap or net worth of $2.65 billion as of August 14, 2025. Its market cap has decreased by -37.59% in one year.
Market Cap
2.65B
Enterprise Value
2.09B
1-Year Change
-37.59%
Ranking
Category
Stock Price
$15.23
Market Cap Chart
Since June 21, 2019, Immunovant's market cap has increased from $124.38M to $2.65B, an increase of 2,034.55%. That is a compound annual growth rate of 64.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 578.26B |
| Johnson & Johnson | 414.98B |
| AbbVie | 349.81B |
| UnitedHealth Group | 236.48B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.57B |
| Novo Nordisk | 222.88B |